HealthBrief Exclusive | Shafiulla Hirehal: Greenspace Herbs bets on AI, spectroscopy and clinical validation to redefine Ayurveda for the world

healthbrief-exclusive-shafiulla-hirehal-of-greenspace-herbs.jpg

In an exclusive interaction with MediaBrief, Shafiulla Hirehal, Director of Greenspace Herbs, speaks about the company’s journey, its science-led approach to botanical innovation, and the philosophy behind Quantum Ayurveda. Hirehal also shares key growth inflection points, the role of AI and spectroscopy in product development, and the brand’s global roadmap.

Hirehal begins by explaining the origins of the company, noting that “Greenspace Herbs came from a simple but powerful idea: people trust the wisdom of Indian plants, but the supply chain is broken and doesn’t have the scientific proof that modern consumers and global markets need.” He says he recognised “a vast gap between the rich heritage of Ayurveda and the rigorous standards of the global nutraceutical industry.”

“We set out on our journey with the goal of closing this gap,” he asserts, recalling how the company “started as an exporter of high-quality, traceable raw herbs, but we quickly evolved.”

According to him, the core market insight was clear: “for India to truly lead, we must move beyond being a commodity supplier to becoming an innovation partner, offering science-backed, standardised botanical extracts.” With this, he adds, “Greenspace Herbs is our vehicle to transform Ayurveda from a traditional practice into a globally respected, evidence-based wellness solution.”

Key inflection points in Greenspace’s growth

Reflecting on the company’s trajectory, Hirehal outlines the major turning points that shaped its evolution. “There have been three key inflection points,” he says. The first came as the company moved “from commodity to extract,” a shift he calls “The First Pivot.”

As he explains, “We first did well with raw herbs, but our first big turning point was when we decided to move into standardised extracts. This turned us from a business-to-business trader into a supplier of value-added ingredients.”





The second major leap, he continues, was investing heavily in research capabilities. “The second was the building of our cutting-edge research and development center,” he shares. “Putting money into technologies like High-Performance Thin-Layer Chromatography (HPTLC) and spectroscopy (Spectroscopy is a technique that identifies what a substance is made of by studying how it interacts with light) changed the game. It let us do more than just talk about quality; it let us show it with data, which gave us a big advantage.”

Finally came what Hirehal calls their “Global Market Entry.” The company’s “successful entry into the US market”—driven by the launch of its Quantum Ayurveda portfolio—was transformative. “We had to meet the highest regulatory and quality standards when we launched our Quantum Ayurveda portfolio there. This raised the level of our whole operation and brand promise. It proved our model on a global scale.”

healthbrief-exclusive-shafiulla-hirehal-of-greenspace-herbs-2.jpg

Defining Quantum Ayurveda beyond the buzzwords

When asked about the rise of Quantum Ayurveda, Hirehal doesn’t mince words. The concept, he says, emerged from “a place of deep respect for Ayurveda and anger at how it has been watered down.” He observes that many brands were either “too traditional and didn’t connect with people around the world,” or they leaned on Ayurveda merely as “a marketing term without any real meaning.”

To counter that, Greenspace developed a more rigorous framework. “We call Quantum Ayurveda a structured, data-driven way of looking at botanical science,” he explains. “‘Quantum’ is the basic, measurable level of how well an herb works.”

Elaborating further, he says the method involves “using spectral fingerprinting to confirm the presence and concentration of each botanical compound in a traditional formulation and then using modern pharmacology to figure out how they work together.” In essence, he adds, “It’s about turning stories into algorithms that can guess what will happen.”

How spectroscopy and AI power botanical innovation

Technologies like spectroscopy and AI serve as cornerstones of this process, Hirehal says, detailing the multi-step approach. “First, we make a unique chemical fingerprint for each batch of raw herb and finished extract. This is similar to a DNA barcode.” The goal, he emphasises, is to ensure “the label matches what’s in the bottle, batch after batch.” With tools like LC-MS, he notes, the company can go even further—“finding and measuring specific active markers.”

The next layer involves predictive intelligence. “AI and Data Analytics — This is the point at which we go from being consistent to being smart,” Hirehal explains. By feeding “decades of agricultural data, spectral fingerprints, and clinical research into AI models,” Greenspace can map potency, optimise cultivation, refine extraction processes, and even develop new herbal combinations.

“For instance, we can link a certain spectral pattern from an Ashwagandha root grown in a certain area to a higher concentration of withanolides,” he notes, adding that “AI helps us find the best conditions for growing, the best ways to extract, and even suggests new blends that work well together based on pattern recognition.”

Validating efficacy through data and clinical evidence

To ensure this innovation remains credible and not mere “tech-washing,” Hirehal stresses the need for rigorous validation. “Our validation is a three-pillar approach,” he says, describing phytochemical, biological, and clinical validation as essential steps in creating “a robust body of evidence.”

He elaborates: “Phytochemical Validation (The ‘What’). This is where spectral analysis (HPTLC) comes in, providing irrefutable lab data that the key active compounds are present in the required amounts.”

“Biological Validation (The ‘How’). We use in vitro and in vivo studies to show how our formulations work by showing how they affect biological pathways at the cellular level.”

And finally, “Clinical Validation (The ‘Proof’). The last step is to test it on people in clinical trials. We are putting money into and working with others on randomised, controlled trials to get the best evidence that healthcare professionals and smart consumers expect.”

healthbrief-exclusive-shafiulla-hirehal-of-greenspace-herbs-3.jpg

Ensuring science over “tech-washing”

Maintaining credibility, he asserts, also requires firm internal checks. “This is a critical question,” he says when discussing tech-washing. “Our safeguard is radical transparency. We have a ‘No Black Box’ policy.”

To uphold this, Greenspace focuses on peer-reviewed research, “claims based on data,” and “standardized protocols” rooted in internationally recognised standards like ISO and GMP. “The science isn’t just for show; it’s part of our standard operating procedures from the farm to the finished product,” he adds.

India’s path to global botanical leadership

Looking outward, Hirehal believes India is well-positioned to lead the global botanicals market—projected to reach over $400 billion by 2030. But the country must act deliberately. “India has 80% of the world’s biodiversity and the basic knowledge of Ayurveda,” he says, calling for coordinated investment in R&D infrastructure, deeper academia–industry linkages, and a global repositioning of Indian botanicals.

He continues, “We all need to change the story about the world. It’s not just about cheap, raw materials; it’s also about advanced, patented, and clinically proven plant-based solutions from India. Greenspace wants to be a leader in this new “Brand India.” new ‘Brand India.’”

Communicating complex science clearly

Communicating such complex ideas to stakeholders requires clarity without oversimplification, he notes. “We make sure that the message is clear, not simple, for each group of people.” For consumers, Greenspace uses relatable analogies—“an ‘herbal ID card’” for spectral fingerprinting, and an “orchestra” to explain synergy.

For investors and partners, he says, “We put the data first,” showcasing charts, protocols and IP pipelines. “We show them the HPTLC charts, the clinical trial protocols, and the IP we are working on. We don’t just think of Quantum Ayurveda as a philosophy; we also think of it as a defensible technology platform and a business model that can grow.”

Digital platforms too, Hirehal says, have become “our main classroom and community center.” Under their “Educate to Empower” strategy, the brand uses content, community engagement, and transparency initiatives—such as the future ability for consumers to scan a QR code to view batch-wise HPTLC reports. “This is the best way to build trust online,” he emphasises.

Balancing tradition and scientific credibility

Addressing how Greenspace balances Ayurveda’s cultural roots with global scientific expectations, Hirehal says, “We don’t see them as enemies; we see them as two sides of the same coin. “Rooted in Tradition, we base our stories on the idea that they are ‘Validated by Science’.”

He continues, “We show respect for the culture by talking about how an herb has been used in the past. For example, we say that Ashwagandha has been used in India for thousands of years to give people more energy. Then we quickly switch to the modern proof: ‘And here is the clinical study that shows a 20% drop in stress scores’. This way honours the past while using the language of the present, which is based on facts.”

healthbrief-exclusive-shafiulla-hirehal-of-greenspace-herbs-4.jpg

India vs US: Market responses to Quantum Ayurveda

The company’s dual-market presence has also offered valuable insights. “The US market is heavily regulated and has a ‘show me the data’ attitude,” Hirehal notes, adding that consumers demand clinical evidence and precise dosage formats.

In contrast, “The Indian market Ayurveda is naturally trusted in this culture. But today’s consumers are pickier and more careful about fake goods. They see the scientific proof as a sign of purity, strength, and high quality. They want a brand to honour the past while also giving them a modern, dependable experience.”

Greenspace Herbs’ vision and roadmap for 2025–26

Looking ahead, Hirehal outlines a clear and ambitious roadmap. “Our larger goal is to make Greenspace Herbs the most trusted place in the world to find botanicals that have been scientifically proven to work.”

For 2025–26, the company’s priorities include deepening IP through patents and advanced clinical trials; “Adding more products to the line; going from single herbs to multi-herb formulations that are specific to conditions like stress, sleep, metabolic health, and immunity, all under the Quantum Ayurveda brand.”

Another key priority focuses on strategic global partnerships, “Working with top international nutraceutical and functional food brands to become their go-to partner for science-based botanical ingredients.”

He also notes that expanding sustainable sourcing is a key priority, adding, “We’re investing in more technology across our farming partnerships to ensure not only quality and traceability, but also climate-resilient practices and fair-trade compliance.”

As Hirehal sums up, “We are working toward a future where healthcare is both fair and effective.”